Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0510
-0.0005 (-0.97%)
At close: Apr 28, 2026

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
212350404523
Upgrade
Market Cap Growth
-46.93%-53.45%25.33%-11.35%96.93%-1.55%
Upgrade
Enterprise Value
242653434823
Upgrade
Last Close Price
0.050.060.120.100.110.06
Upgrade
PS Ratio
63.7769.9081.7972.2145.94-
Upgrade
PB Ratio
-3.40-3.73-8.46-5.30-7.29-5.51
Upgrade
EV/Sales Ratio
71.9276.9486.0577.2548.64-
Upgrade
Debt / Equity Ratio
-0.47-0.47-0.53-0.40-0.35-0.42
Upgrade
Net Debt / Equity Ratio
-0.43-0.43-0.48-0.39-0.35-0.25
Upgrade
Net Debt / EBITDA Ratio
-0.56-0.56-0.73-1.18-0.76-0.23
Upgrade
Net Debt / FCF Ratio
-0.82-0.82-0.88-1.15-0.71-1.05
Upgrade
Asset Turnover
0.400.400.500.320.36-
Upgrade
Quick Ratio
0.040.040.040.010.000.09
Upgrade
Current Ratio
0.080.080.140.150.230.45
Upgrade
Return on Assets (ROA)
-355.41%-355.41%-200.92%-89.58%-64.62%-141.40%
Upgrade
Return on Capital Employed (ROCE)
78.10%78.10%66.10%33.00%46.60%110.80%
Upgrade
Earnings Yield
-25.34%-23.12%-9.38%-7.70%-7.82%-24.01%
Upgrade
FCF Yield
--14.16%-6.51%-6.39%-6.69%-4.39%
Upgrade
Buyback Yield / Dilution
-0.11%-0.11%-0.07%-0.01%-2.76%-3.81%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.